Global Debate on Nicotine Product Taxation

Regulations by 2FIRSTS.ai
Jan.09.2024
Global Debate on Nicotine Product Taxation
As e-cigarette and HNB products gain popularity, global debate over nicotine product tax rates intensifies, challenging policymakers to find a balance between economic and health considerations.

According to a report by Moneyweb on January 9th, the debate over nicotine product taxation is intensifying globally, as e-cigarettes and HNB products continue to gain popularity. This issue is causing disagreements between economists and public health experts, posing a challenge for countries on how to make rational decisions regarding the tax policies for these nicotine products.

 

Economists argue for considering both the costly economic consequences and individual freedoms when implementing taxation measures, to ensure that taxed prices reflect all costs associated with production and consumption. However, health experts lean towards prioritizing health impacts above economic effects, advocating for high taxes and regulations to reduce the detrimental effects of nicotine products on public health.

 

Currently, countries worldwide are striving to find a balance between the economy and public health. South Africa is reconsidering its tobacco and nicotine taxation policy, taking into account income inequality and public health challenges.

 

Economists believe that incorporating all net costs into the prices of nicotine products can provide consumers with accurate information to make informed decisions. On the other hand, health experts advocate for government intervention in the form of high taxes, bans, and regulations to limit the consumption of nicotine products in order to reduce their negative impact on health.

 

South Africa, a country grappling with income inequality and public health challenges, has opted for a risk-based nicotine product tax rate due to its fragile healthcare system and the heightened vulnerability of low-income individuals to non-communicable diseases. This decision has sparked a wide-ranging debate on its wisdom.

 

Overall, the global issue of nicotine taxation involves various interests and perspectives, with finding a balance between economic and health concerns being a common challenge for policymakers around the world.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Morrisons Partners with Vape Retailer to Open Concessions in 400+ Stores
Morrisons Partners with Vape Retailer to Open Concessions in 400+ Stores
According to The Grocer, Morrisons has reached an agreement with The E-Cig Store to open vaping concessions in more than 400 supermarkets. The first unit will open next month in Rotherham. The deal will expand compliant vaping product offerings and follows Morrisons’ ongoing cooperation with rival retailer VPZ.
Nov.28 by 2FIRSTS.ai
Phnom Penh “Mystery House” raided: authorities seize over 300,000 smoking devices and related items
Phnom Penh “Mystery House” raided: authorities seize over 300,000 smoking devices and related items
A Phnom Penh venue selling electronic smoking devices — nicknamed the “Mystery House” — was raided on the night of January 15, 2026, with authorities seizing over 300,000 items and arresting the 58-year-old owner. Seized evidence included smoking machines, cigarette heads, bottles of vape juice and marijuana grinding machines.
Jan.19 by 2FIRSTS.ai
Tobacco-Free Kids Condemns PMI for Marketing Zyn to Youth via F1 Sponsorship
Tobacco-Free Kids Condemns PMI for Marketing Zyn to Youth via F1 Sponsorship
Yolonda C. Richardson, President and CEO of the Campaign for Tobacco-Free Kids, issued a statement on December 10, 2025, condemning Philip Morris International (PMI) for partnering with Ferrari to promote Zyn nicotine pouches on Formula 1 cars. She said PMI’s claim that the sponsorship targets adults is misleading, as F1’s audience has become increasingly young—with over 4 million children aged 8–12 now following the sport.
Dec.12 by 2FIRSTS.ai
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai
Mexico’s ENCODAT 2025 finds smoking rate falls as vaping rises
Mexico’s ENCODAT 2025 finds smoking rate falls as vaping rises
Results from Mexico’s ENCODAT 2025 indicate a structural shift in tobacco and nicotine use: past-month combustible tobacco use among the general population (ages 12–65) declined to 15.1%, down from 17.6% in 2016, while past-month e-cigarette use increased to 2.6%, up from 1.1%.
Dec.25 by 2FIRSTS.ai
AIRSCREAM Unlocks Pan-European Nicotine Pouch Market for B2B Partners with Full-Service EU OEM Solutions
AIRSCREAM Unlocks Pan-European Nicotine Pouch Market for B2B Partners with Full-Service EU OEM Solutions
Showcased at PouchEx Stockholm, AIRSCREAM’s end-to-end OEM ecosystem demonstrates how brands can enter the fast-growing European nicotine pouch market with greater speed, confidence, and regulatory readiness.
Dec.04